LATOYA GIPSON: Open Payments
NPI 1497942007 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$106 in 6 payments from 4 companies in 2025. Trend: 2023 $258 · 2024 $75 · 2025 $106
Food & beverage: $106
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $50 |
| Organon LLC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
| ABBVIE INC. | 1 | $14 |
Products named: MOUNJARO, NEXPLANON, Veozah, ZEPBOUND, LO LOESTRIN FE.
Industry payments across LA — which companies pay providers there.
